Journal of the American Chemical Society
ARTICLE
The solid residue is separated by column chromatography on silica with
CH2Cl2. First the residual educt is eluted as an orange-yellow fraction of
greenish yellow fluorescence (100 mg, 51% of recovered educt mono-
mer 1). The first product, dimer 1, is eluted as an orange fraction of
orange-yellow fluorescence followed by the second product, trimer 1, as
a violet-red fraction of orange fluorescence. Concentrated to dryness,
dimer 1 gives a red solid and trimer 1 a deep red solid.
Dimer 2 (2,20-bi-(8-mesityl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-
3a,4a-diaza-s-indacenyl)):Yield:21mg, 10%.1H NMR (300 MHz, CDCl3):
δ = 6.95 (s, 2H; 2 ꢁ mesityl-CH), 6.91 (s, 2H; 2 ꢁ mesityl-CH), 5.97 (s,
2H; 6/60-CH), 2.57 (s, 6H; CH3), 2.36 (s, 6H; CH3), 2.32 (s, 6H; CH3),
2.12 (s, 6H; CH3), 2.05 (s, 6H; CH3), 1.39 (s, 6H; CH3), 1.13 (s, 6H;
CH3). 13C NMR (100 MHz, CDCl3): δ = 155.7, 154.4, 142.8, 141.8,
140.4, 138.8, 135.1, 134.9, 131.4, 131.0, 130.6, 129.3 (2C; 2 ꢁ mesityl-
CH), 129.1 (2C; 2 ꢁ mesityl-CH), 124.5, 121.2 (2C; 6/60-CH), 21.3,
19.7, 19.7, 14.8 (br s, 2C; 5/50-CCH3), 13.6, 13.5 (br s, 2C; 3/30-CCH3),
12.1. 19F NMR (376 MHz, CDCl3): δ = ꢀ146.7 (q, JBF = 33 Hz, 4F; 2 ꢁ
BF2). 11B NMR (128 MHz, CDCl3):δ=0.57(t, JBF =33Hz, 2B;2ꢁ BF2).
HRMS (APCIþ): m/z calcd for C44H49B2F4N4 [MþH]þ, 731.4085;
found, 731.4083.
Dimer 1 (2,20-bi-(1,3,5,7,8-pentamethyl-4,4-difluoro-4-bora-3a,4a-
diaza-s-indacenyl)): Yield: 55 mg, 27%. 1H NMR (400 MHz, CD2Cl2):
δ = 6.13 (s, 2H; 6/60-CH), 2.67 (s, 6H; CH3), 2.51 (s, 6H; CH3), 2.46 (s,
6H; CH3), 2.32 (s, 6H; CH3), 2.23 (s, 6H; CH3). 13C NMR (100 MHz,
CD2Cl2): δ = 154.7, 153.4, 142.6, 142.5, 140.1, 133.0, 132.7, 125.2, 122.0
(2C; 6/60-CH), 17.8, 17.3, 15.9, 14.8 (br s, 2C; 5/50-CCH3), 13.5 (br s, 2C;
3/30-CCH3). 19F NMR (376 MHz, CD2Cl2): δ = ꢀ146.7 (q, JBF = 33 Hz,
4F; 2 ꢁ BF2). 11B NMR (128 MHz, CD2Cl2): δ = 0.37 (t, JBF = 33 Hz, 2B;
2 ꢁ BF2). HRMS (APCIþ): m/z calcd for C28H33B2F4N4 [MþH]þ,
523.2822; found, 523.2830.
Trimer 2 (2,20,60,200-tri-(8-mesityl-1,3,5,7-tetramethyl-4,4-difluoro-
4-bora-3a,4a-diaza-s-indacenyl)): Yield: 6 mg, 3%. 1H NMR (300 MHz,
CDCl3): δ = 6.95 (s, 2H; 2 ꢁ mesityl-CH), 6.92 (s, 4H; 4 ꢁ mesityl-CH),
5.98 (s, 2H; 6/600-CH), 2.56 (s, 6H; CH3), 2.37 (s, 6H; CH3), 2.34 (s,
6H; CH3), 2.32 (s, 6H; CH3), 2.31 (s, 3H; CH3), 2.12 (s, 6H; CH3), 2.07
(s, 6H; CH3), 2.04 (s, 6H; CH3), 1.39 (s, 6H; CH3), 1.13 (s, 12H; CH3).
13C NMR (100 MHz, CDCl3): δ = 155.9, 155.0, 154.3, 142.9, 141.8,
141.7, 140.8, 140.4, 138.9, 138.8, 135.1, 134.9, 134.9, 131.5, 131.4, 131.1,
130.8, 130.6, 129.3 (4C; 4 ꢁ mesityl-CH), 129.1 (2C; 2 ꢁ mesityl-CH),
124.8, 124.4, 121.2 (2C; 6/600-CH), 21.3, 19.8, 19.8, 19.7, 14.8 (br s, 2C;
5/500-CCH3), 13.6, 13.6 (br s) 13.5 (br s), 12.1, 12.1. 19F NMR (376 MHz,
CDCl3): δ = ꢀ146.8 (m, 6F; 3 ꢁ BF2). 11B NMR (128 MHz, CDCl3):
δ = 0.63 (pseudo t, JBF = 33 Hz, 3B; 3 ꢁ BF2). HRMS (APCIþ): m/z
calcd for C66H72B3F6N6 [MþH]þ, 1095.6007; found, 1095.6027.
Preparation of polymer. To a solution of 1,3,5,7-tetramethyl-8-
mesityl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (monomer 2) (116 mg,
0.318 mmol) in dry CH2Cl2 (30 mL) is added anhydrous FeCl3 (207 mg,
1.27 mmol) at room temperature. H2O (100 mL) is added to the re-
action mixture after stirring for 22 h at room temperature. The se-
parated organic phase is dried over Na2SO4 and concentrated to dryness
on a rotary evaporator. The blue, solid residue is separated by column
chromatography on neutral aluminum oxide (Brockmann activity IV).
The smaller units are washed away with CH2Cl2. The polymer is finally
eluted as a blue fraction with CH2Cl2/MeOH = 1:1 and pure MeOH. Phase
separation from the coeluted water and filtration leads after evaporation
to the product as a violet solid.
Trimer 1 (2,20,60,200-tri-(1,3,5,7,8-pentamethyl-4,4-difluoro-4-bora-
3a,4a-diaza-s-indacenyl)): Yield: 17 mg, 9%. 1H NMR (400 MHz,
CD2Cl2): δ = 6.14 (s, 2H; 6/600-CH), 2.75 (s, 3H; 80-CCH3), 2.68 (s,
6H; CH3), 2.51 (s, 6H; CH3), 2.47 (s, 6H; CH3), 2.35 (s, 6H; CH3), 2.33
(s, 6H; CH3), 2.26 (s, 6H; CH3), 2.24 (s, 6H; CH3). 13C NMR: Due to
the low solubility no analyzable 13C NMR spectrum could be recorded.
19F NMR (376 MHz, CD2Cl2): δ = ꢀ146.6 (m, 6F; 3 ꢁ BF2). 11B NMR
(128 MHz, CD2Cl2): δ = 0.59 (t, JBF = 31 Hz, 3B; 3 ꢁ BF2). HRMS
(APCIþ): m/z calcd for C42H48B3F6N6 [MþH]þ, 783.4118; found,
783.4120.
Preparation of monomer 2 (8-Mesityl-1,3,5,7-tetramethyl-4,4-
difluoro-4-bora-3a,4a-diaza-s-indacene). To a solution of 2,4,6-tri-
methylbenzaldehyde (0.73 mL, 5 mmol) and 2,4-dimethyl-1H-pyrrole
(1.28 mL, 12.5 mmol) in dry CH2Cl2 (250 mL) is added a solution of
trifluoroacetic acid (50 μL, 0.65 mmol) in dry CH2Cl2 (2.5 mL) slowly
at room temperature. 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (1.128 g,
5 mmol) is added after 3 h stirring under ice bath cooling and stirred for
10 min. The solution is stirred for an additional 1 h at room temperature.
NEt3 (10 mL, 72 mmol) is added, followed by slow addition of BF3 Et2O
3
(10 mL, 81 mmol). The reaction mixture is washed after 2 h of stirring at
room temperature with saturated aqueous Na2CO3 solution (3 ꢁ 50 mL),
dried over Na2SO4, and concentrated on a rotary evaporator. The brown,
oily residue is purified by column chromatography on silica with n-pentane/
CH2Cl2 = 5:1, then 2:1, then pure CH2Cl2. The product fraction with
greenish fluorescence is dried to yield a red-brown solid.
Yield: 18 mg. 1H NMR (300 MHz, CD2Cl2): δ = 6.94 (br s; mesityl-
CH), 6.00 (s; CH), 3.09ꢀ2.80 (br m), 2.56ꢀ0.88 (br m). 19F NMR
(376 MHz, CD2Cl2): δ = ꢀ146.6 (m; BF2). 11B NMR (128 MHz,
CD2Cl2): δ = 1.08 (t; BF2). GPC (THF, 23 °C, polystyrene standard):
Mn = 8732, Mw = 17635, D(Mw/ Mn) = 2.02.
Yield: 1.698 g, 93%. 1H NMR (300 MHz, CDCl3): δ = 6.94 (s, 2H;
2 ꢁ mesityl-CH), 5.96 (s, 2H; 2/6-CH), 2.56 (s, 6H; CH3), 2.33 (s, 3H;
CH3), 2.10 (s, 6H; CH3), 1.38 (s, 6H; CH3). 13C NMR (75 MHz, CDCl3):
δ = 155.2, 142.4, 141.8, 138.7, 135.1, 131.3, 130.8, 129.1 (2C; 2 ꢁ
mesityl-CH), 120.9 (2C; 2/6-CH), 21.3, 19.6, 14.8 (br s, 2C; 3/5-CCH3),
13.5. 19F NMR (376 MHz, CDCl3): δ = ꢀ146.5 (q, JBF = 33 Hz, 2F;
BF2). 11B NMR (128 MHz, CDCl3): δ = 0.69 (t, JBF = 33 Hz, 1B; BF2).
HRMS (ESIþ): m/z calcd for C22H25BF2N2Na [MþNa]þ, 389.1971;
found, 389.1983.
Preparation45,52 of aza-BODIPY monomer. To a solution of tetra-
phenyl azadipyrromethene (414 mg, 0.92 mmol) in dry CH2Cl2 (160 mL)
is added dry i-Pr2EtN (1.8 mL, 10.1 mmol), and the mixture is stirred
for 15 min at room temperature. Freshly destilled BF3 Et2O (1.8 mL,
3
14.3 mmol) is slowly added and stirred for 24 h at room temperature.
The solution is washed with H2O (3 ꢁ 100 mL), dried over Na2SO4, and
concentrated on a rotary evaporator. The product is dried under vacuum
to yield a black-blue solid.
Preparation of dimer 2 and trimer 2. To a solution of 1,3,5,7-
tetramethyl-8-mesityl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (mono-
mer 2) (227 mg, 0.64 mmol) in dry CH2Cl2 (30 mL) is added anhydrous
FeCl3 (402 mg, 2.48 mmol) at room temperature. The orange solution
rapidly turns deep green-red-violet. The reaction is quenched after 25 min
stirring by addition of MeOH (25 mL). The organic phase is washed with
H2O (3 ꢁ 100 mL), dried over Na2SO4, and concentrated to dryness on a
rotary evaporator. The solid residue is separated by column chromatog-
raphy on silica with CH2Cl2. First the residual educt is eluted as greenish
yellow fluorescing fraction. The first product, dimer 2, is eluted as an
orange fluorescing fraction, followed by the second product, trimer 2, as a
reddish fluorescing fraction. Concentrated to dryness, dimer 2 gives a red
solid and trimer 2 a violet solid.
Yield: 468 mg, 100%. 1H NMR (300 MHz, CDCl3): δ = 8.17ꢀ7.98 (m,
8H), 7.56ꢀ7.35 (m, 12H), 6.99 (s, 2H; 2 ꢁ β-CH). 13C NMR (100 MHz,
CDCl3): δ = 159.7 (2C; aza-BODIPY-C), 145.7 (2C; aza-BODIPY-C),
144.3 (2C; aza-BODIPY-C), 132.4, 131.7, 131.0, 129.7 (t, J = 3 Hz),
129.6, 129.5, 128.8, 128.7, 119.3 (2C; aza-BODIPY-CH). 19F NMR
(376 MHz, CDCl3): δ = ꢀ133.6 (q, JBF = 31 Hz, 2F; BF2). 11B NMR
(128 MHz, CDCl3): δ = 0.57 (t, JBF = 31 Hz, 1B; BF2). HRMS
(APCIþ): m/z calcd for C32H23BF2N3 [MþH]þ, 498.1951; found,
498.1948.
Preparation of aza-BODIPY dimer. To a solution of aza-BODIPY
monomer (50 mg, 0.100 mmol) in dry CH2Cl2 (20 mL) is added an-
hydrous FeCl3 (65 mg, 0.401 mmol) at room temperature. After stirring
8636
dx.doi.org/10.1021/ja2010219 |J. Am. Chem. Soc. 2011, 133, 8633–8645